FDA Approves Hercessi, the Sixth Trastuzumab Biosimilar
The recent FDA approval of Hercessi expands access to a treatment previously burdened by high costs. Hercessi joins the 5 other biosimilars already on the market.
Stay updated with breaking news from Managed Care. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The recent FDA approval of Hercessi expands access to a treatment previously burdened by high costs. Hercessi joins the 5 other biosimilars already on the market.
On April 20, 2024, Governor Hochul signed the New York State Budget for fiscal year 2024-2025 into law. The Budget includes legislation that significantly changes the state’s Consumer...
Dignity Health and Aetna, a CVS Health Company, have reached agreement on a new, multi-year contract that allows Aetna members to maintain in-network access to Dignity Health services, facilities and
Healthcare should take a fresh look at its thinking on conflicts of interest. It could be that those with the most conflicts useful things to say about a subject.
Racial disparities in end-of-life care, the role of wellness and faith in minority health, award-winning research on health disparities, societal factors impacting cardiometabolic health, and rising mental health challenges among US youth are all covered this week in the Center on Health Equity and Access.